All treatments
Treatment
LUMYKRAS 120 mg film-coated tablets clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
A Phase 1/2, First in Human Study of DCC-3116 as Monotherapy and in Combination With RAS/MAPK Pathway Inhibitors in Patients With Advanced or Metastatic Solid Tumors With RAS/MAPK Pathway Mutations
This study is testing a new medicine, DCC-3116, for people with advanced cancers. It will see how safe it is and how well it works, both on its own and when given with other established cancer drugs. This is an early-stage trial to find the best way to use this new treatment.
For: Non-Small Cell Lung Cancer · Metastatic Solid Tumor · Advanced Solid TumorGermany · Italy · Spain - Ongoing, recruitingTherapeutic use (Phase IV)
Rivaroxaban sotorasib interaction study (the ROSIE-study)
This study is looking at how two medicines, sotorasib (LUMYKRAS) and rivaroxaban (Xarelto), interact when taken together. Researchers want to see if taking sotorasib affects how much rivaroxaban stays in your body and for how long. It involves healthy volunteers.
For: Healthy subjectsNetherlands